These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32015540)

  • 1. A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder.
    Phan BN; Bohlen JF; Davis BA; Ye Z; Chen HY; Mayfield B; Sripathy SR; Cerceo Page S; Campbell MN; Smith HL; Gallop D; Kim H; Thaxton CL; Simon JM; Burke EE; Shin JH; Kennedy AJ; Sweatt JD; Philpot BD; Jaffe AE; Maher BJ
    Nat Neurosci; 2020 Mar; 23(3):375-385. PubMed ID: 32015540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Na
    Martinowich K; Das D; Sripathy SR; Mai Y; Kenney RF; Maher BJ
    Mol Psychiatry; 2023 Jan; 28(1):76-82. PubMed ID: 36224259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
    Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
    J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.
    Chen HY; Bohlen JF; Maher BJ
    Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome.
    Sripathy SR; Wang Y; Moses RL; Fatemi A; Batista DA; Maher BJ
    Stem Cell Res; 2020 Oct; 48():102001. PubMed ID: 32971458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome.
    Dennys CN; Vermudez SAD; Deacon RJM; Sierra-Delgado JA; Rich K; Zhang X; Buch A; Weiss K; Moxley Y; Rajpal H; Espinoza FD; Powers S; Ávila AS; Gogliotti RG; Cogram P; Niswender CM; Meyer KC
    Neurotherapeutics; 2024 Sep; 21(5):e00376. PubMed ID: 38876822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression.
    Cleary CM; James S; Maher BJ; Mulkey DK
    Nat Commun; 2021 Oct; 12(1):5962. PubMed ID: 34645823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
    Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
    Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons.
    Jung M; Häberle BM; Tschaikowsky T; Wittmann MT; Balta EA; Stadler VC; Zweier C; Dörfler A; Gloeckner CJ; Lie DC
    Mol Autism; 2018; 9():20. PubMed ID: 29588831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
    Sparber P; Filatova A; Anisimova I; Markova T; Voinova V; Chuhrova A; Tabakov V; Skoblov M
    Eur J Med Genet; 2020 Dec; 63(12):104088. PubMed ID: 33069932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants.
    van der Laan L; Lauffer P; Rooney K; Silva A; Haghshenas S; Relator R; Levy MA; Trajkova S; Huisman SA; Bijlsma EK; Kleefstra T; van Bon BW; Baysal Ö; Zweier C; Palomares-Bralo M; Fischer J; Szakszon K; Faivre L; Piton A; Mesman S; Hochstenbach R; Elting MW; van Hagen JM; Plomp AS; Mannens MMAM; Alders M; van Haelst MM; Ferrero GB; Brusco A; Henneman P; Sweetser DA; Sadikovic B; Vitobello A; Menke LA
    HGG Adv; 2024 Jul; 5(3):100289. PubMed ID: 38571311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
    Liu Y; Guo Y; Liu P; Li F; Yang C; Song J; Hu J; Xin D; Chen Z
    Int J Dev Neurosci; 2018 Jun; 67():51-54. PubMed ID: 29604340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tcf4 dysfunction alters dorsal and ventral cortical neurogenesis in Pitt-Hopkins syndrome mouse model showing sexual dimorphism.
    Espinoza F; Carrazana R; Retamal-Fredes E; Ávila D; Papes F; Muotri AR; Ávila A
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167178. PubMed ID: 38636614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCF4 Mutations Disrupt Synaptic Function Through Dysregulation of RIMBP2 in Patient-Derived Cortical Neurons.
    Davis BA; Chen HY; Ye Z; Ostlund I; Tippani M; Das D; Sripathy SR; Wang Y; Martin JM; Shim G; Panchwagh NM; Moses RL; Farinelli F; Bohlen JF; Li M; Luikart BW; Jaffe AE; Maher BJ
    Biol Psychiatry; 2024 Apr; 95(7):662-675. PubMed ID: 37573005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt-Hopkins syndrome.
    Bohlen JF; Cleary CM; Das D; Sripathy SR; Sadowski N; Shim G; Kenney RF; Buchler IP; Banerji T; Scanlan TS; Mulkey DK; Maher BJ
    Brain; 2023 Aug; 146(8):3331-3346. PubMed ID: 37068912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional mislocalization of Pten drives precocious maturation in oligodendrocytes and aberrant myelination in model of autism spectrum disorder.
    Lee H; Thacker S; Sarn N; Dutta R; Eng C
    Transl Psychiatry; 2019 Jan; 9(1):13. PubMed ID: 30664625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
    Aldeeri AA; Abu-El-Haija A
    Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
    Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
    J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.
    Tripon F; Bogliș A; Micheu C; Streață I; Bănescu C
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32481733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composite Sleep Problems Observed Across Smith-Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt-Hopkins Syndrome, and ASD.
    Gandhi A; Zhou D; Alaimo J; Chon E; Fountain MD; Elsea SH
    J Autism Dev Disord; 2021 Jun; 51(6):1852-1865. PubMed ID: 32845423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.